New pediatric low-grade astrocytoma tumor registry
Although there are approximately 1,000 new pediatric low-grade astrocytoma (LGA) patients diagnosed each year, scientists still have a lot to learn about why pediatric LGAs occur and how they behave. Research efforts in this area have been hampered by limited access to tumor samples.
To overcome this obstacle, pediatric neurooncologist Mark Kieran, MD, PhD, and colleagues at Dana-Farber Cancer Institute are advancing efforts to establish a pediatric LGA-specific tumor registry.
The central resource will support investigators working to discover the mutations that cause pediatric LGAs, ultimately enabling them to develop more effective treatments by targeting the abnormalities in these tumors.
To learn more about the pediatric LGA registry or to receive an alert once we are accepting samples, please call 617-632-2680.